Core Viewpoint - Recent reports reveal that numerous online accounts have been spreading false claims about children's products being made from industrial waste, primarily to drive traffic for e-commerce sales [1][3][10] Summary by Sections Nature of the Rumors - The rumors claim that children's creams, body lotions, and laundry products are made from industrial waste, which is identified as a "rumor-based traffic generation" tactic [3][5] - The spread of these rumors can be traced back to videos that began circulating approximately seven months ago, with a significant increase in activity noted in the last month [5][7] Mechanism of Spread - The rumors utilize alarming headlines and fabricated data, such as claims of harmful substances exceeding safety limits by 40 times, to attract attention [8][9] - The content is often produced using a template that can be easily modified with different locations, dates, and statistics, allowing for mass dissemination of misinformation [8][11] Impact on Consumers - The spread of these rumors has created significant anxiety among parents, who are particularly sensitive to issues regarding children's health [8][11] - Comments from the public indicate a growing awareness of the manipulative tactics used by these accounts, with many expressing skepticism towards the credibility of such claims [9][10] Industry Response - Experts emphasize the need for stricter content regulation and the establishment of a rumor database to improve the identification of false information [13][14] - Regulatory bodies and platforms are beginning to take action, including the removal of misleading content and the suspension of accounts involved in spreading these rumors [16][17] Long-term Implications - The ongoing spread of these rumors poses a threat to the reputation of legitimate children's product brands, potentially leading to a loss of consumer trust [11][14] - The situation highlights the necessity for the cosmetics industry to maintain transparency and uphold product integrity to foster a healthy market environment [16][17]

Core Viewpoint - Recent rumors regarding children's health products, particularly vitamin D3, have created significant anxiety among parents, driven by misleading information and exaggerated claims on social media platforms [1][4][6] Summary by Sections Rumors and Claims - Claims about children's vitamin D3 being harmful have been circulating since February, with various versions of the narrative suggesting that a high percentage of households are affected and that harmful substances are present in excessive amounts [4][5] - Specific alarming statements include that "toxic vitamin D3 covers 90% of families" and that harmful substances exceed safety limits by factors ranging from 10 to 80 times [1][5] Tactics Used - The misinformation often follows a template, with similar phrasing and claims across different accounts, indicating a coordinated effort to spread fear [3][6] - Videos claiming that most vitamin supplements are fake and harmful lack credible sources and often use distorted visuals, suggesting a reliance on sensationalism rather than factual reporting [3] Motivations Behind Misinformation - The primary goal of these rumors appears to be generating anxiety to drive traffic and sales of alternative products, with many videos promoting supposedly "qualified" products after spreading fear [6][8] - Experts note that these tactics exploit parental concerns for profit, indicating a calculated approach to manipulate emotions for commercial gain [11][12] Regulatory Response - Experts emphasize the need for targeted regulatory measures to combat this type of misinformation, particularly those that exploit children's health topics [12] - Recent initiatives by regulatory bodies aim to address the spread of negative emotions and misinformation on social media platforms, highlighting the importance of collaborative efforts in monitoring and controlling such content [13]

Core Viewpoint - The article highlights the alarming trend of "rumor-based marketing" targeting children's health products, where false information is spread to create fear and anxiety among parents, ultimately leading to the promotion of certain products [1][12][14] Group 1: Nature of Rumors - Various alarming claims about children's health products, such as "toxic vitamin D3" and "industrial waste in children's creams," are being circulated on social media platforms [1][12] - The content often lacks credible sources, with conflicting statistics about the prevalence of "toxic vitamin D3" in households, ranging from 67.8% to 92% [4][10] - The same accounts frequently post contradictory information, indicating a systematic approach to spreading these rumors [7][10] Group 2: Impact on Public Perception - The spread of these rumors creates significant anxiety among parents, as evidenced by the overwhelming concern expressed in comment sections of related videos [3][12] - The misinformation disrupts the normal flow of information, leading to a decline in public trust and increasing societal anxiety [12][14] Group 3: Marketing Tactics - The accounts responsible for spreading these rumors often recommend "safe products" after instilling fear, effectively monetizing the anxiety they create [12][14] - These accounts utilize fabricated authority by misrepresenting credible sources to lend legitimacy to their claims, further misleading parents [14][15] Group 4: Regulatory Response - The article discusses the need for regulatory measures to combat the spread of such harmful misinformation, including establishing rapid verification channels and increasing penalties for rumor-spreading accounts [15] - It emphasizes the importance of a multi-faceted approach to ensure the protection of children in the digital space [15]

润本生物技术股份有限公司 Runben Biotechnology Co., Ltd. （广州经济技术开发区新庄五路 3 号） 首次公开发行股票并在主板上市 招股说明书 保荐人（主承销商） 新疆乌鲁木齐市高新区（新市区）北京南路 358 号 大成国际大厦 20 楼 2004 室 润本生物技术股份有限公司 招股说明书 发行人声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发 行人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表 明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保 证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发 行人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行 承担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风 险。 1-1-1 润本生物技术股份有限公司 招股说明书 | 发行股票类型： | 人民币普通股（A 股） | | | | | --- | --- | --- | --- | --- | | 发行股数： | 本次发行 6,069.00 | | ...

润本生物技术股份有限公司 Runben Biotechnology Co., Ltd. 首次公开发行股票并在主板上市 招股说明书 （注册稿） 本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本 招股说明书不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当 保荐人（主承销商） 新疆乌鲁木齐市高新区（新市区）北京南路 358 号 （广州经济技术开发区新庄五路 3 号） 以正式公告的招股说明书作为投资决定的依据。 大成国际大厦 20 楼 2004 室 润本生物技术股份有限公司 招股说明书 发行人声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发 行人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表 明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保 证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发 行人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行 承担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风 险。 1-1-1 招股说明书 | > | | - ...

润本生物技术股份有限公司 Runben Biotechnology Co., Ltd. （广州经济技术开发区新庄五路 3 号） 首次公开发行股票并在主板上市 招股说明书 （注册稿） 本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本 招股说明书不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当 以正式公告的招股说明书作为投资决定的依据。 保荐人（主承销商） 新疆乌鲁木齐市高新区（新市区）北京南路 358 号 大成国际大厦 20 楼 2004 室 | 发行股票类型： | 人民币普通股（A 股） | | --- | --- | | 发行股数： | 本次发行不超过 6,069.00 万股，占公司发行后总股本的 | | | 比例不低于 15%，本次发行股份均为公开发行的新股， | | | 公司原有股东不公开发售股份。 | | 每股面值： | 元人民币 1.00 | | 每股发行价格： | 【】元人民币 | | 预计发行日期： | 【】年【】月【】日 | | 拟上市的证券交易所和板块： | 上海证券交易所主板 | | 发行后总股本： | 不超过 40,459.3314 万股 | | 保荐人（主承销 ...